Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Walch

Showing results (121-130 of 250) with videos related to

Pageof 25
Sort By:
Endocrine-Related Cancer|February 20, 2021
Transcriptomic landscape of radiation-induced murine thyroid proliferative lesionsElena Stauffer, Peter Weber, Theresa Heider, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|March 5, 2009
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancersKen Herrmann, Axel Walch, Benjamin Balluff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinomaRudolf Reiter, Peter Gais, Uta Jütting, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2022
Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sectionsLisa Kreutzer, Peter Weber, Theresa Heider, et al.
The Journal of Pathology|September 24, 2017
A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasionChristiane Daniela Fichter, Camilla Maria Przypadlo, Achim Buck, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer PatientsRudolf Napieralski, Gabriele Schricker, Gert Auer, et al.
Oncotargets and Therapy|June 13, 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphomaNicolas Graf, Zhoulei Li, Ken Herrmann, et al.
British Journal of Cancer|January 24, 2024
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancerJun Wang, Na Sun, Thomas Kunzke, et al.
ACS Nano|August 28, 2023
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different WaysJian Shen, Na Sun, Jun Wang, et al.
American Journal of Cancer Research|April 14, 2016
Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcomeJulia Dorn, Alexandra Yassouridis, Axel Walch, et al.
Pageof 25

Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Endocrine-Related Cancer|February 20, 2021
Transcriptomic landscape of radiation-induced murine thyroid proliferative lesionsElena Stauffer, Peter Weber, Theresa Heider, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|March 5, 2009
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancersKen Herrmann, Axel Walch, Benjamin Balluff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinomaRudolf Reiter, Peter Gais, Uta Jütting, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 31, 2022
Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sectionsLisa Kreutzer, Peter Weber, Theresa Heider, et al.
The Journal of Pathology|September 24, 2017
A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasionChristiane Daniela Fichter, Camilla Maria Przypadlo, Achim Buck, et al.
Breast Care (Basel, Switzerland)|November 1, 2021
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer PatientsRudolf Napieralski, Gabriele Schricker, Gert Auer, et al.
Oncotargets and Therapy|June 13, 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphomaNicolas Graf, Zhoulei Li, Ken Herrmann, et al.
British Journal of Cancer|January 24, 2024
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancerJun Wang, Na Sun, Thomas Kunzke, et al.
ACS Nano|August 28, 2023
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different WaysJian Shen, Na Sun, Jun Wang, et al.
American Journal of Cancer Research|April 14, 2016
Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcomeJulia Dorn, Alexandra Yassouridis, Axel Walch, et al.
Pageof 25